SCP
MRK icon

Sandhill Capital Partners’s Merck MRK Stock Holding History

Sandhill Capital Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.3M Sell
44,020
-3,773
-8% -$436K 0.46% 38
2025
Q4 		$5.03M Sell
47,793
-301
-0.6% -$28.3K 0.36% 45
2025
Q3 		$4.04M Buy
48,094
+121
+0.3% +$9.97K 0.28% 50
2025
Q2 		$3.8M Buy
47,973
+1,644
+4% +$131K 0.27% 48
2025
Q1 		$4.16M Buy
46,329
+3,599
+8% +$336K 0.34% 44
2024
Q4 		$4.25M Buy
42,730
+369
+0.9% +$38K 0.33% 45
2024
Q3 		$4.81M Buy
42,361
+1,625
+4% +$193K 0.34% 42
2024
Q2 		$5.04M Sell
40,736
-187
-0.5% -$24.1K 0.39% 39
2024
Q1 		$5.4M Sell
40,923
-976
-2% -$120K 0.43% 34
2023
Q4 		$4.57M Sell
41,899
-4,796
-10% -$498K 0.38% 37
2023
Q3 		$4.81M Buy
46,695
+618
+1% +$66.6K 0.45% 35
2023
Q2 		$5.32M Sell
46,077
-2,364
-5% -$268K 0.48% 29
2023
Q1 		$5.15M Sell
48,441
-6,416
-12% -$693K 0.49% 34
2022
Q4 		$6.09M Sell
54,857
-873
-2% -$89.2K 0.65% 28
2022
Q3 		$4.8M Sell
55,730
-451
-0.8% -$40.3K 0.55% 32
2022
Q2 		$5.12M Buy
56,181
+28,964
+106% +$2.57M 0.55% 33
2022
Q1 		$2.23M Buy
27,217
+2,635
+11% +$208K 0.19% 52
2021
Q4 		$1.88M Buy
24,582
+1,839
+8% +$146K 0.15% 57
2021
Q3 		$1.71M Buy
22,743
+2,434
+12% +$185K 0.14% 55
2021
Q2 		$1.58M Buy
20,309
+2,059
+11% +$153K 0.12% 58
2021
Q1 		$1.34M Buy
18,250
+1,713
+10% +$126K 0.11% 60
2020
Q4 		$1.29M Sell
16,537
-108
-0.6% -$8.26K 0.12% 58
2020
Q3 		$1.32M Buy
16,645
+855
+5% +$67K 0.13% 54
2020
Q2 		$1.17M Buy
15,790
+1,111
+8% +$83.6K 0.14% 52
2020
Q1 		$1.08M Buy
14,679
+620
+4% +$48.7K 0.14% 50
2019
Q4 		$1.22M Buy
14,059
+1,823
+15% +$150K 0.14% 51
2019
Q3 		$983K Buy
12,236
+921
+8% +$73.8K 0.12% 52
2019
Q2 		$905K Buy
11,315
+656
+6% +$50.2K 0.11% 44
2019
Q1 		$846K Buy
10,659
+897
+9% +$67.1K 0.12% 44
2018
Q4 		$712K Sell
9,762
-120
-1% -$8.47K 0.12% 46
2018
Q3 		$669K Buy
9,882
+428
+5% +$27.3K 0.1% 53
2018
Q2 		$548K Sell
9,454
-53
-0.6% -$2.99K 0.09% 61
2018
Q1 		$494K Buy
9,507
+203
+2% +$11K 0.08% 62
2017
Q4 		$500K Buy
9,304
+305
+3% +$16.9K 0.09% 59
2017
Q3 		$550K Sell
8,999
-241
-3% -$14.6K 0.11% 53
2017
Q2 		$565K Buy
9,240
+287
+3% +$17.5K 0.12% 48
2017
Q1 		$543K Sell
8,953
-3,353
-27% -$203K 0.13% 49
2016
Q4 		$691K Buy
12,306
+1,088
+10% +$63.7K 0.19% 37
2016
Q3 		$668K Buy
11,218
+1,000
+10% +$58.5K 0.2% 36
2016
Q2 		$562K Buy
10,218
+106
+1% +$5.64K 0.18% 43
2016
Q1 		$511K Sell
10,112
-2,098
-17% -$103K 0.17% 44
2015
Q4 		$615K Buy
12,210
+89
+0.7% +$4.49K 0.2% 40
2015
Q3 		$571K Buy
12,121
+215
+2% +$11.4K 0.19% 44
2015
Q2 		$647K Sell
11,906
-2,818
-19% -$158K 0.2% 47
2015
Q1 		$808K Buy
14,724
+5
+0% +$283 0.27% 42
2014
Q4 		$798K Sell
14,719
-282
-2% -$15.7K 0.27% 42
2014
Q3 		$849K Buy
15,001
+883
+6% +$49.6K 0.3% 38
2014
Q2 		$779K Buy
14,118
+375
+3% +$20.5K 0.28% 36
2014
Q1 		$744K Buy
13,743
+97
+0.7% +$5.02K 0.28% 37
2013
Q4 		$652K Buy
13,646
+1,101
+9% +$50.3K 0.26% 40
2013
Q3 		$570K Buy
12,545
+21
+0.2% +$959 0.26% 37
2013
Q2 		$555K Buy
+12,524
New +$559K 0.27% 38

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sandhill Capital Partners's MRK Position: Q1 2026 in Review

Sandhill Capital Partners reduced its Merck (MRK) stake by 7.9% in Q1 2026, selling an estimated $436K and leaving 44,020 shares worth $5.3M. The position accounts for 0.46% of the portfolio, ranked #38.

Sandhill Capital Partners first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.09M in Q4 2022. 3,782 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Sandhill Capital Partners held 44,020 shares of Merck worth $5.3M as of Q1 2026.
  • Sandhill Capital Partners sold 3,773 Merck shares in Q1 2026, an estimated $436K.
  • Merck made up 0.46% of Sandhill Capital Partners's portfolio in Q1 2026, its #38 holding.
  • Sandhill Capital Partners first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Sandhill Capital Partners's Merck position peaked at $6.09M in Q4 2022.
  • 3,782 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Sandhill Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.